» Authors » Charidimos Tsagkas

Charidimos Tsagkas

Explore the profile of Charidimos Tsagkas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 504
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bedard S, Karthik E, Tsagkas C, Pravata E, Granziera C, Smith A, et al.
Med Image Anal . 2025 Jan; 101:103473. PMID: 39874684
Spinal cord segmentation is clinically relevant and is notably used to compute spinal cord cross-sectional area (CSA) for the diagnosis and monitoring of cord compression or neurodegenerative diseases such as...
2.
Muller J, Lu P, Cagol A, Ruberte E, Shin H, Ocampo-Pineda M, et al.
Neurology . 2024 Aug; 103(6):e209604. PMID: 39213476
Background And Objectives: Myelin and iron play essential roles in remyelination processes of multiple sclerosis (MS) lesions. χ-separation, a novel biophysical model applied to multiecho T2*-data and T2-data, estimates the...
3.
Cagol A, Tsagkas C, Granziera C
Neuroimaging Clin N Am . 2024 Jun; 34(3):335-357. PMID: 38942520
In recent decades, advances in neuroimaging have profoundly transformed our comprehension of central nervous system demyelinating diseases. Remarkable technological progress has enabled the integration of cutting-edge acquisition and postprocessing techniques,...
4.
Donnay C, Okar S, Tsagkas C, Gaitan M, Poorman M, Reich D, et al.
Front Neurol . 2024 Jun; 15:1330203. PMID: 38854960
Ultra-low field (ULF) magnetic resonance imaging (MRI) holds the potential to make MRI more accessible, given its cost-effectiveness, reduced power requirements, and portability. However, signal-to-noise ratio (SNR) drops with field...
5.
Papadopoulou A, Pfister A, Tsagkas C, Gaetano L, Sellathurai S, DSouza M, et al.
Clin Neurophysiol . 2024 Mar; 161:122-132. PMID: 38461596
Objective: To explore associations of the main component (P100) of visual evoked potentials (VEP) to pre- and postchiasmatic damage in multiple sclerosis (MS). Methods: 31 patients (median EDSS: 2.5), 13...
6.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin S, Leber S, Tsagkas C, et al.
Neurology . 2024 Jan; 102(1):e207768. PMID: 38165377
Background And Objectives: Progression independent of relapse activity (PIRA) is a crucial determinant of overall disability accumulation in multiple sclerosis (MS). Accelerated brain atrophy has been shown in patients experiencing...
7.
Donnay C, Dieckhaus H, Tsagkas C, Gaitan M, Beck E, Mullins A, et al.
Front Neuroimaging . 2023 Dec; 2:1252261. PMID: 38107773
Introduction: Automatic whole brain and lesion segmentation at 7T presents challenges, primarily from bias fields, susceptibility artifacts including distortions, and registration errors. Here, we sought to use deep learning algorithms...
8.
Muller J, Cagol A, Lorscheider J, Tsagkas C, Benkert P, Yaldizli O, et al.
JAMA Neurol . 2023 Oct; 80(11):1232-1245. PMID: 37782515
Importance: Emerging evidence suggests that progression independent of relapse activity (PIRA) is a substantial contributor to long-term disability accumulation in relapsing-remitting multiple sclerosis (RRMS). To date, there is no uniform...
9.
Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Amann M, Barakovic M, et al.
Mult Scler Relat Disord . 2023 Feb; 71:104545. PMID: 36758461
Background: Although cervical spinal cord (cSC) area is an established biomarker in MS, there is currently a lack of longitudinal assessments of cSC gray and white matter areas. Objective: We...
10.
Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Barakovic M, Amann M, et al.
Mult Scler . 2022 Dec; 29(6):702-718. PMID: 36550626
Background: Spinal cord (SC) gray and white matter pathology plays a central role in multiple sclerosis (MS). Objective: We aimed to investigate the extent, pattern, and clinical relevance of SC...